EBV antigen dominant epitope peptide and application thereof
The invention provides an EBV antigen dominant epitope peptide, an EBV antigen comprises an EBV gH antigen and an EBV gL antigen, and the amino acid sequences of the EBV gH antigen dominant epitope peptide are SEQ ID NO.1, SEQ ID NO.2, SEQ ID NO.3, SEQ ID NO.4 and SEQ ID NO.5; the amino acid sequenc...
Gespeichert in:
Hauptverfasser: | , , , |
---|---|
Format: | Patent |
Sprache: | chi ; eng |
Schlagworte: | |
Online-Zugang: | Volltext bestellen |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | The invention provides an EBV antigen dominant epitope peptide, an EBV antigen comprises an EBV gH antigen and an EBV gL antigen, and the amino acid sequences of the EBV gH antigen dominant epitope peptide are SEQ ID NO.1, SEQ ID NO.2, SEQ ID NO.3, SEQ ID NO.4 and SEQ ID NO.5; the amino acid sequences of the EBV gL antigen dominant epitope peptide are as follows: SEQ ID NO. 6, SEQ ID NO. 7, SEQ ID NO. 8 and SEQ ID NO. 9. The dominant epitope peptide provided by the invention has EBV gH antigen and EBV gL antigen specific dominant T cell epitopes, and provides reference for EBV immunology and vaccine research.
本发明提出了一种EBV抗原优势表位肽,EBV抗原包括EBV gH抗原和EBV gL抗原,所述EBV gH抗原优势表位肽的氨基酸序列为SEQ ID NO.1、SEQ ID NO.2、SEQ ID NO.3、SEQ ID NO.4和SEQ ID NO.5;所述EBV gL抗原优势表位肽的氨基酸序列为:SEQ ID NO.6、SEQ ID NO.7、SEQ ID NO.8和SEQ ID NO.9。本发明的优势表位肽具有EBV gH抗原和EBV gL抗原特异性优势T细胞表位,为EBV免疫学与疫苗研究提供了参考。 |
---|